Descriptions

TLR8 (Toll-like receptor 8) is an endosomal receptor that plays a key role in innate and adaptive immunity by recognizing pathogen-associated molecular patterns such as single-stranded nucleic acids from viruses and bacteria. TLR8 is a type I transmembrane protein characterized by an extracellular leucine-rich repeat (LRR) domain, a transmembrane helix, and an intracellular Toll/interleukin-1 receptor (TIR) homology domain. TLR8 is monomeric in the absence of ligands and transforms into an activated dimer form on ligand binding, which allows for dimerization of the intracellular TIR domain and subsequent signaling. TLR8 possess a long inserted loop region (Z-loop), consisting of about 30 amino acid residues, between LRR14 and LRR15, and the processing by proteolytic cleavage at the Z-loop produces functional TLR8 capable of TLR8 dimerization, ligand binding, and signaling in endolysosomes. The uncleaved Z-loop prevents formation of the TLR8 dimer, which is essential for its activation, by preventing the dimerization partner by steric hindrance. In autoinhibited state, Z-loop is sandwiched by LRR8, LRR11-LRR13, and LRR18-LRR19.

Autoinhibitory domains (AIDs)

Target domain

25-824 (LRR domains)

Relief mechanism

Cleavage

Assay

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P58682

Entry ID Method Resolution Chain Position Source
AF-P58682-F1 Predicted AlphaFoldDB

86 variants for P58682

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389594411 3 N>T No EVA
rs261598459 43 S>A No EVA
rs3412560393 61 I>L No EVA
rs3389594385 90 T>N No EVA
rs223472812 119 S>N No EVA
rs3389562834 122 N>I No EVA
rs3389584065 125 V>G No EVA
rs254214752 130 D>G No EVA
rs3389584093 142 E>V No EVA
rs3389540506 153 N>Y No EVA
rs3389540518 178 Y>F No EVA
rs3412527999 183 Q>H No EVA
rs3411255567 185 F>L No EVA
rs3389576351 185 F>S No EVA
rs3411366869 194 N>K No EVA
rs3412642817 195 L>V No EVA
rs3389491352 197 H>Y No EVA
rs251795045 230 M>V No EVA
rs3412945610 231 N>I No EVA
rs3389577133 246 L>Q No EVA
rs3412560377 251 N>S No EVA
rs3389533397 262 C>Y No EVA
rs3412971008 264 P>A No EVA
rs3411255525 264 P>R No EVA
rs3389550767 293 S>F No EVA
rs236002778 303 E>D No EVA
rs212847065 356 S>P No EVA
rs248887741 360 K>M No EVA
rs1132632384 362 R>C No EVA
rs1132275155 363 S>F No EVA
rs243485080 366 K>T No EVA
rs217020350 380 K>E No EVA
rs227095799 384 H>P No EVA
rs246188726 384 H>Y No EVA
rs255475062 387 S>N No EVA
rs229052869 389 P>S No EVA
rs31638088 416 D>N No EVA
rs3389577109 425 I>K No EVA
rs3411366898 429 L>* No EVA
rs3411255539 430 D>H No EVA
rs3389592360 432 T>I No EVA
rs3389578741 444 P>H No EVA
rs3412806505 459 Y>* No EVA
rs3389592384 469 Q>* No EVA
rs3389586920 469 Q>L No EVA
rs31637312 488 G>E No EVA
rs220899481 509 T>S No EVA
rs257785264 529 T>A No EVA
rs3412736671 532 R>* No EVA
rs3389587021 545 H>Y No EVA
rs3389583615 560 S>N No EVA
rs3389533336 580 L>I No EVA
rs3412942500 584 H>L No EVA
rs3412642842 603 E>K No EVA
rs3412806513 604 L>F No EVA
rs3389592445 607 S>E* No EVA
rs3411255506 608 G>E No EVA
rs3389581427 609 N>D No EVA
rs3389584026 611 L>F No EVA
rs31637309 613 R>H No EVA
rs3389576437 623 W>* No EVA
rs3389576291 623 W>* No EVA
rs3389562820 631 N>K No EVA
rs31637306 651 L>F No EVA
rs3389586923 659 E>* No EVA
rs3389550891 691 L>M No EVA
rs234872463 697 C>Y No EVA
rs3389582644 710 L>P No EVA
rs216974417 724 S>P No EVA
rs252275377 745 S>T No EVA
rs3389540482 775 R>Q No EVA
rs3389583646 804 S>N No EVA
rs214652691 836 A>T No EVA
rs3389578714 840 H>D No EVA
rs3389582662 842 L>P No EVA
rs1133010183 851 Y>D No EVA
rs3389577131 869 T>A No EVA
rs251013101 883 S>T No EVA
rs3389491370 910 E>V No EVA
rs3389594347 911 R>S No EVA
rs3402728423 913 W>G No EVA
rs3389594398 944 S>R No EVA
rs3389578708 947 F>S No EVA
rs3389578735 979 Q>H No EVA
rs3389533370 989 K>M No EVA
rs3389533399 1030 R>T No EVA

No associated diseases with P58682

22 regional properties for P58682

Type Name Position InterPro Accession
domain Toll/interleukin-1 receptor homology (TIR) domain 869 - 1016 IPR000157
repeat Leucine-rich repeat 65 - 99 IPR001611-1
repeat Leucine-rich repeat 271 - 318 IPR001611-2
repeat Leucine-rich repeat 501 - 555 IPR001611-3
repeat Leucine-rich repeat 576 - 597 IPR001611-4
repeat Leucine-rich repeat 624 - 667 IPR001611-5
repeat Leucine-rich repeat 704 - 725 IPR001611-6
repeat Leucine-rich repeat 728 - 749 IPR001611-7
repeat Leucine-rich repeat, typical subtype 66 - 85 IPR003591-1
repeat Leucine-rich repeat, typical subtype 120 - 143 IPR003591-2
repeat Leucine-rich repeat, typical subtype 195 - 218 IPR003591-3
repeat Leucine-rich repeat, typical subtype 281 - 304 IPR003591-4
repeat Leucine-rich repeat, typical subtype 305 - 329 IPR003591-5
repeat Leucine-rich repeat, typical subtype 388 - 411 IPR003591-6
repeat Leucine-rich repeat, typical subtype 412 - 435 IPR003591-7
repeat Leucine-rich repeat, typical subtype 520 - 543 IPR003591-8
repeat Leucine-rich repeat, typical subtype 574 - 597 IPR003591-9
repeat Leucine-rich repeat, typical subtype 629 - 652 IPR003591-10
repeat Leucine-rich repeat, typical subtype 678 - 701 IPR003591-11
repeat Leucine-rich repeat, typical subtype 703 - 725 IPR003591-12
repeat Leucine-rich repeat, typical subtype 727 - 749 IPR003591-13
repeat BspA-type LRR region 355 - 423 IPR026906

Functions

Description
EC Number
Subcellular Localization
  • Endosome membrane ; Single-pass type I membrane protein
  • Endosomal localization confers distinctive proteolytic processing
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
endosome membrane The lipid bilayer surrounding an endosome.
external side of plasma membrane The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

4 GO annotations of molecular function

Name Definition
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
double-stranded RNA binding Binding to double-stranded RNA.
pattern recognition receptor activity Combining with a pathogen-associated molecular pattern (PAMP), a structure conserved among microbial species to initiate an innate immune response.
single-stranded RNA binding Binding to single-stranded RNA.

16 GO annotations of biological process

Name Definition
canonical NF-kappaB signal transduction The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
cellular response to mechanical stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
defense response to virus Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
inflammatory response The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
innate immune response Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
negative regulation of interleukin-12 production Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-12 production.
positive regulation of innate immune response Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.
positive regulation of interferon-alpha production Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.
positive regulation of interferon-beta production Any process that activates or increases the frequency, rate, or extent of interferon-beta production.
positive regulation of interleukin-1 beta production Any process that activates or increases the frequency, rate, or extent of interleukin-1 beta production.
positive regulation of interleukin-6 production Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
positive regulation of interleukin-8 production Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.
positive regulation of type II interferon production Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
regulation of protein phosphorylation Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein.
toll-like receptor 8 signaling pathway The series of molecular signals initiated by a ligand binding to the endolysosomal toll-like receptor 8.
toll-like receptor signaling pathway The series of molecular signals initiated by a ligand binding to a toll-like receptor of a target cell. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate an innate immune response.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9NR97 TLR8 Toll-like receptor 8 Homo sapiens (Human) EV
P58681 Tlr7 Toll-like receptor 7 Mus musculus (Mouse) SS
Q9EQU3 Tlr9 Toll-like receptor 9 Mus musculus (Mouse) SS
10 20 30 40 50 60
MENMPPQSWI LTCFCLLSSG TSAIFHKANY SRSYPCDEIR HNSLVIAECN HRQLHEVPQT
70 80 90 100 110 120
IGKYVTNIDL SDNAITHITK ESFQKLQNLT KIDLNHNAKQ QHPNENKNGM NITEGALLSL
130 140 150 160 170 180
RNLTVLLLED NQLYTIPAGL PESLKELSLI QNNIFQVTKN NTFGLRNLER LYLGWNCYFK
190 200 210 220 230 240
CNQTFKVEDG AFKNLIHLKV LSLSFNNLFY VPPKLPSSLR KLFLSNAKIM NITQEDFKGL
250 260 270 280 290 300
ENLTLLDLSG NCPRCYNAPF PCTPCKENSS IHIHPLAFQS LTQLLYLNLS STSLRTIPST
310 320 330 340 350 360
WFENLSNLKE LHLEFNYLVQ EIASGAFLTK LPSLQILDLS FNFQYKEYLQ FINISSNFSK
370 380 390 400 410 420
LRSLKKLHLR GYVFRELKKK HFEHLQSLPN LATINLGINF IEKIDFKAFQ NFSKLDVIYL
430 440 450 460 470 480
SGNRIASVLD GTDYSSWRNR LRKPLSTDDD EFDPHVNFYH STKPLIKPQC TAYGKALDLS
490 500 510 520 530 540
LNNIFIIGKS QFEGFQDIAC LNLSFNANTQ VFNGTEFSSM PHIKYLDLTN NRLDFDDNNA
550 560 570 580 590 600
FSDLHDLEVL DLSHNAHYFS IAGVTHRLGF IQNLINLRVL NLSHNGIYTL TEESELKSIS
610 620 630 640 650 660
LKELVFSGNR LDRLWNANDG KYWSIFKSLQ NLIRLDLSYN NLQQIPNGAF LNLPQSLQEL
670 680 690 700 710 720
LISGNKLRFF NWTLLQYFPH LHLLDLSRNE LYFLPNCLSK FAHSLETLLL SHNHFSHLPS
730 740 750 760 770 780
GFLSEARNLV HLDLSFNTIK MINKSSLQTK MKTNLSILEL HGNYFDCTCD ISDFRSWLDE
790 800 810 820 830 840
NLNITIPKLV NVICSNPGDQ KSKSIMSLDL TTCVSDTTAA VLFFLTFLTT SMVMLAALVH
850 860 870 880 890 900
HLFYWDVWFI YHMCSAKLKG YRTSSTSQTF YDAYISYDTK DASVTDWVIN ELRYHLEESE
910 920 930 940 950 960
DKSVLLCLEE RDWDPGLPII DNLMQSINQS KKTIFVLTKK YAKSWNFKTA FYLALQRLMD
970 980 990 1000 1010 1020
ENMDVIIFIL LEPVLQYSQY LRLRQRICKS SILQWPNNPK AENLFWQSLK NVVLTENDSR
1030
YDDLYIDSIR QY